Schaison, G <br/><br/>
Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenance.  [electronic resource] 

 -  Haematology and blood transfusion  1987 
 - 461-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0171-7111 
<br/><br/><label>Standard No.: </label>10.1007/978-3-642-71213-5_81  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amsacrine--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Child<br/>Clinical Trials as Topic<br/>Cytarabine--administration & dosage<br/>Drug Administration Schedule<br/>Humans<br/>Leukemia, Lymphoid--drug therapy<br/>Mercaptopurine--administration & dosage<br/>Methotrexate--administration & dosage<br/>Random Allocation<br/>Risk<br/>Vincristine--administration & dosage